AiVita Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. The Company leverages its unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development. AiVita’s proprietary methodologies enables them to turn therapeutic discovery into reality, providing revolutionary cell-based treatments and healthcare products to the patients who need them.

AiVita’s technologies include a patient-specific cancer immunotherapy applicable to most solid tumor types, currently being investigated for the treatment of ovarian cancer. The treatment aims to inform the patient’s own immune system how to seek out and destroy cancer initiating cells, the very cells responsible for tumor growth and metastasis. Other programs in active development include the Company’s skin care technology, commercially available through Alphaeon as PROVOQUETM Facial Serum. PROVOQUETM Facial Serum is a patented stem cell technology which helps address several key signs of skin aging, including the appearance of wrinkles, skin firmness, softness and radiance.